Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Esflurbiprofen Patch Under Heat, Occlusion, and Exercise
NCT06870422Phase 1Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of esflurbiprofen in soft tissue injury and osteoarthritis (OA) (4 arms), sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoints: Area under the plasma concentration versus time curve over 24 hours, Peak plasma concentration and 2 more. Started Feb 2025; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
soft tissue injuryosteoarthritis (OA)
Beyond the preview
Go deeper on NCT06870422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870422.